Nephrotic Syndrome Treated by Micro-Chinese Medicine Osmotherapy

nephrotic-syndrome,Micro-Chinese Medicine Osmotherapy,Chinese MedicineFor patients:

Shi Jiazhuang Kidney Disease Hospital creates Micro-Chinese Medicine Osmotherapy in treating kidney disease. This therapy is able to stop renal fibrosis progression and has the functions of dilating blood vessels, anti-inflammation, anti-coagulation and degradation.

Name: Mr Liu

Gender: Male

Age: 21

Country: China

Diagnose: Nephrotic Syndrome

General information of the patient:

Liu has facial swelling for more than 10 years. 10 years ago, he had cold and then experienced facial edema. Routine urine test in his local hospital shows that protein 2+, normal kidney function. He was diagnosed with nephrotic syndrome and took medications to prevent inflammation. But there was no any improvement. Later he took prednisone 12 tablets. In this way his condition gets alleviated but it has a higher relapse. To seek further treatment, he came to our hospital for treatment.

Diagnosis in our hospital:

Nephrotic syndrome, chronic kidney disease (CKD) stage 3, renal hypertension, renal anemia, acid-based disorders and electrolyte disorder.

Treatment process and results:

After his hospitalization, western medicines are used to control complications.

Micro-Chinese Medicine Osmotherapy is used two times per day to block renal fibrosis inflammatory response and further injury.

Creatinine level decreases from 152umol/L to 81umol/L,Urine nitrogen decreases to 4.3 from 16.7 and uric acid reduces from 671 to 362.

If you want to know more information about Micro-Chinese Medicine Osmotherapy and Nephrotic Syndrome, please leave us a message or send emails to us. We will reply you as soon as possible.



viber/whatsapp: +86 18730617149, +86 13503211882

Previous:Nephrotic Syndrome Treated by Toxin-Removing Therapy to Improve Proteinuria

Next:What Will Happen with the Development of Nephrotic Syndrome

Tag:Micro-Chinese Medicine OsmotherapyChinese Medicinenephrotic-syndrome

  • Gender: